Your browser doesn't support javascript.
loading
[Development in the last 20 years of anti-HER2 targeted therapy for breast cancer].
Liu, B; Li, J B; Jiang, Z F.
Affiliation
  • Liu B; Department of Oncology, the Fifth Medical Center of People's Liberation Army General Hospital, Beijing 100071, China.
  • Li JB; Department of Oncology, the Fifth Medical Center of People's Liberation Army General Hospital, Beijing 100071, China.
  • Jiang ZF; Department of Oncology, the Fifth Medical Center of People's Liberation Army General Hospital, Beijing 100071, China.
Zhonghua Wai Ke Za Zhi ; 61(2): 89-94, 2023 Feb 01.
Article in Zh | MEDLINE | ID: mdl-36720616
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Guideline / Prognostic_studies Limits: Female / Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Wai Ke Za Zhi Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Guideline / Prognostic_studies Limits: Female / Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Wai Ke Za Zhi Year: 2023 Type: Article Affiliation country: China